James Hardie stock gained 1.31 percent after a new Buy call from Melius Research

Published on 10/07/2026 at 04:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

James Hardie stock drew a Buy call from Melius Research on October 6, 2026, with a USD 36 target. Fiscal Q1 revenue reached USD 1.47 billion against USD 1.42 billion expected.

James Hardie, AU000000JHX1, Illustration mit AI erstellt.

James Hardie stock (ISIN AU000000JHX1) was last at USD 25.53 on the NYSE on October 6, 2026 at 4:00 p.m. ET, up 1.31 percent from the prior close. The move followed Melius Research analyst Michael Rehaut's initiation with a Buy rating and a USD 36 price target, as Markets Insider reported on October 6, 2026.

Analyst target reaches USD 36

The Melius target stands USD 10.47 above the October 6 price, a 41.0 percent premium. The call adds a fresh bullish view to a stock whose 52-week range runs from USD 16.46 to USD 31.43, leaving the latest price USD 5.90 below the yearly high.

MarketBeat counts 10 Buy ratings and three Hold ratings, producing a Moderate Buy consensus and an average price target of USD 34.00. That average is USD 8.47 above the latest price, or 33.2 percent using the price-target comparison.

Q1 revenue beats estimates

James Hardie reported fiscal Q1 2027 revenue of USD 1.47 billion, compared with the USD 1.42 billion analyst estimate, while EPS reached USD 0.36 against USD 0.32 expected, according to MarketBeat. The revenue comparison represents a 3.5 percent beat, while EPS exceeded consensus by USD 0.04.

The latest quarter also provides the operating base for management's longer-term plan. In its September 15, 2026 investor-day release, James Hardie set an annual organic growth target of 4 percent to 7 percent above market, raised its fiscal 2027 free cash flow target and said it expected to reach USD 125 million of cost synergies one year ahead of schedule.

Stock remains below yearly high

James Hardie stock was last at USD 25.53 on the NYSE on October 6, 2026 at 4:00 p.m. ET, with a market capitalization of USD 14.8 billion and volume of 7,806,585 shares. The combination of a USD 36 analyst target, a USD 34.00 consensus target and the latest revenue beat gives investors three measurable benchmarks for the next results cycle.